# Ramadansvasten lijkt veilig bij chronisch hartfalen — systematische review

*geplaatst 2026-10-23 · Hartfalen · Current cardiology reports · doi 10.1007/s11886-026-02434-9 · https://hartvaat.nl/2026/10/14/ramadansvasten-lijkt-veilig-bij-chronisch-hartfalen-systematische-review/*

Een systematische review van zeven studies toont aan dat vasten tijdens Ramadan niet gepaard gaat met meer ziekenhuisopnames, verslechtering van de klinische status of hogere sterfte bij patiënten met chronisch hartfalen. De bevindingen suggereren dat vasten relatief veilig is mits onder medische begeleiding en met goede medicatie-adherentie. Voor cardiologen en huisartsen betekent dit dat patiënten gerust kunnen vasten na individuele risicobeoordeling, hoewel grotere prospectieve studies nodig zijn om de veiligheid verder te bevestigen.

## English: Ramadan Fasting in Chronic Heart Failure: A Systematic Review.

A systematic review of seven studies found that Ramadan fasting is not associated with increased hospitalizations, clinical deterioration, or higher mortality in patients with chronic heart failure. The evidence suggests that fasting is relatively safe when undertaken with appropriate medical supervision and strict adherence to prescribed therapies. Clinicians can reassure stable heart failure patients about fasting after individual risk assessment, though larger prospective trials are needed to confirm these observations.

## Abstract (original, from the publication)

BACKGROUND: Chronic heart failure (CHF) is a significant global health concern, affecting over 64 million individuals worldwide. During Ramadan, the ninth month of the Islamic calendar, Muslims abstain from food, drink, smoking, and sexual activity between dawn and sunset. This systematic review investigates the potential impact of Ramadan observance in patients with CHF. METHODS: In accordance with JBI and PRISMA guidelines, a comprehensive literature search was performed across PubMed, Scopus, and Web of Science to identify clinical studies examining the effects of Ramadan fasting in patients with CHF. Review articles, case reports, animal studies, editorials, conference abstracts, and commentaries were excluded. Risk of bias was evaluated using the JBI critical appraisal tools. RESULTS: The search identified 137 articles, of which seven met the inclusion criteria. The included studies were mostly conducted in MENA region. Overall, Ramadan fasting was not associated with increased hospitalization rates, deterioration in clinical status, or higher mortality among patients with heart failure. CONCLUSION: This study suggest that fasting may be relatively safe when undertaken with appropriate medical supervision and adherence to prescribed treatment. Nonetheless, larger prospective studies are warranted to further validate these observations.

Auteurs: Ahad Nourmohammad, Negar Sheibani, Nima Ghasemzadeh, Amirreza Naseri, Elnaz Javanshir, Erfan Banisefid

---
Bron: Current cardiology reports, https://doi.org/10.1007/s11886-026-02434-9. Bijgewerkt 2026-10-16T01:23:21Z. Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.